Current Month
Article Features
  Age-Specific Overall Risk of Breast, Ovarian Cancer Among Women with BRCA1/2 Genetic Mutations
Are Wealthier People More Likely to Receive a Diagnosis of Cancer?
Balance, Gait Negatively Impacted After Chemotherapy Treatment
Breast Cancer Risk Reduced in Women with Diabetes Who Take Low-Dose Aspirin
Confusion Over Symptoms May Be Affecting Whether Women Take Tamoxifen for Breast Cancer
Does MRI Plus Mammography Improve Detection of New Breast Cancer After Breast Conservation Therapy?
Fat Tissue May Impede Radiotherapy for Breast Cancer Patients
Genetic Tests Help Identify Relative Risk of 25 Cancer-Associated Mutations
How Family and Friends Influence Breast Cancer Treatment Decisions
Mammograms: Are We Overdiagnosing Small Tumors?
Medicaid Restrictions Linked to Increased Late-Stage Breast Cancer Diagnoses
Metastatic Breast Cancer Cells Use Hedgehog to “Evilize” Docile Neighbors
Microscope Can Scan Tumors During Surgery and Examine Cancer Biopsies in 3-D
More Breast Cancers Were Diagnosed at Early Stage After Affordable Care Act Took Effect
New Treatment Hope for Women with BRCA1 Breast Cancers
Researchers Investigate the Wisdom of Crowds in the Realm of Visual Searches
Study Shows Biomarkers Can Predict Which ER-Positive Breast Cancer Patients Respond Best to First-Line Therapy
Time to Initiating Cancer Therapy is Increasing, Associated with Worsening Survival
Trends in Reoperation After Initial Lumpectomy for Breast Cancer


Trends in Reoperation After Initial Lumpectomy for Breast Cancer

Writing in the journal JAMA Oncology, Monica Morrow, M.D., of Memorial Sloan Kettering Cancer Center, New York, and coauthors investigated the impact of a 2014 consensus statement endorsing a minimal negative margin for invasive breast cancer on postlumpectomy surgery and final surgical treatment.

There had been wide variation in attitudes about what was considered an appropriate negative margin width for lumpectomy. Reoperation after initial lumpectomy has major treatment implications for patients.

The population-based study, which included 3,729 women undergoing initial lumpectomy between 2013 and 2015, describes the approach by surgeons to surgical margins for invasive breast cancer and changes in postlumpectomy surgery rates and final surgical treatment following the 2014 consensus statement that endorsed a margin of "no ink on tumor."

Read More of the Main Article

 
Visit the Ezine


Visit the BreastCenter

Visit the Quality Corner
Avon Breast Cancer Crusade - AVON the company for women

  This website is supported in part by an unrestricted educational grant provided by Avon